APA (7th ed.) Citation

AL, C., JL, S., DI, S., SK, G., R, P., BW, B., . . . RA, V. (2022). Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes. Diabetes technology & therapeutics, 24(3), 178. https://doi.org/10.1089/dia.2021.0319

Chicago Style (17th ed.) Citation

AL, Carlson, et al. "Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes." Diabetes Technology & Therapeutics 24, no. 3 (2022): 178. https://doi.org/10.1089/dia.2021.0319.

MLA (9th ed.) Citation

AL, Carlson, et al. "Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes." Diabetes Technology & Therapeutics, vol. 24, no. 3, 2022, p. 178, https://doi.org/10.1089/dia.2021.0319.